Elanco Animal Health Incorporated Common Stock (ELAN)
R&D Expense Growth
-5.15%
Quarterly · Period ending:
ELAN R&D Expense Growth
Latest reported-5.15%period ending
Latest reported-5.15%period ending
ELAN Quarterly R&D Growth (QoQ) (0.00% → -5.15%)
Latest values, visible window
High-resolution chart · PNG
ELAN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.1546% | |
| 4.3011% | |
| 4.4944% | |
| -3.2609% | |
| -2.1277% | |
| 16.0494% | |
| -6.8966% | |
| -2.2472% | |
| 2.2989% | |
| 10.1266% | |
| -8.1395% | |
| 6.1728% | |
| 0% | |
| 1.25% | |
| 2.5641% | |
| -4.878% | |
| 1.2346% | |
| -11.9565% | |
| -2.1277% | |
| 0% | |
| 5.618% | |
| -21.0293% | |
| 27.9228% | |
| 48.3165% | |
| -11.0778% | |
| -0.7429% | |
| -3.7196% | |
| 1.5988% | |
| 7.3323% | |
| 4.91% | |
| 3.7351% | |
| -4.0717% | |
| -5.8282% | |
| 5.1613% | |
| 0.1616% | |
| -3.2056% | |
| 0% | |
| 0% |